Skip to content
  • Saturday, 12 September 2026
  • 6:27 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Idvynso Secures FDA Approval, Charting a New Course in HIV Treatment While Biktarvy Maintains Market Dominance
Pharmaceutical R&D

Idvynso Secures FDA Approval, Charting a New Course in HIV Treatment While Biktarvy Maintains Market Dominance

Teuku Ryan Apr 23, 2026 0

MSD (Merck & Co) has achieved a significant milestone in the fight against Human Immunodeficiency Virus (HIV) with the U.S.…

Read More
Biotech & Genetic Research

Biotech Sector Thrives on Collaboration and Innovation, Charting Course for Future Discoveries at Major 2026 Scientific Gatherings

Jia Lissa Apr 9, 2026 0

The past two weeks have underscored a vibrant and increasingly collaborative biotech landscape, characterized by strategic partnerships aimed at addressing…

Read More
Biotech & Genetic Research

Leading Nanomedicine Experts Unveil Definitive Guide to Cancer Applications, Addressing Translational Hurdles and Charting Future Innovations

Jia Lissa Mar 14, 2026 0

Liverpool John Moores University (LJMU) Professor of Nanomedicine, Imran Saleem, and Qassim University Professor of Pharmaceutics, Ahmed AH Abdellatif, long-time…

Read More
Artificial Heart Patients Exhibit Potential for Heart Muscle Regeneration Offering New Hope for Heart Failure TreatmentThe Evolving Landscape of Locally Advanced Head and Neck Squamous Cell Carcinoma Treatment Presents New Avenues for InnovationFDA Leadership Turmoil Intensifies as Key Officials Ousted Amidst Political ManeuveringGerman Researchers Identify CD99L2 Gene as Key Driver of X-linked Spastic Ataxia
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ